Skip to main content

Table 5 Comparison of Serum AFP, AFP-L3, and CTCs Levels between Non-recurrent Group and Recurrent Group Relapsed before and after Microwave Ablation of Liver Cancer

From: Combined detection of circulating tumor cells, α-fetoprotein heterogene-3 and α-fetoprotein in the early diagnosis of HCC for the prediction of efficacy, prognosis, recurrence after microwave ablation

Group Time Cases AFP(ng/mL) AFP-L3(%) CTCs
Non-recurrence Group Before surgery 57 157.34(67.93~508.71) 14.72(13.87~15.65) 2.23(1.95~2.53)
6 months after surgery 57 62.17(38.57~107.76)a 7.01(5.13~8.93)a 1.70(1.52~1.91)a
Recurrence Group Before surgery 48 216.82(97.12~731.85)a 17.51(15.44~19.26)a 2.65(2.14~2.93)a
6 months after surgery 48 351.06(216.84~485.29)ab 21.38(18.91~23.73)ab 3.05(2.62~3.31)ab
  1. Note: Compared with the non-recurring group before surgery, aP<0.05; compared with the non-recurring group at 6 months after surgery, bP<0.05